ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Afyren

Afyren (ALAFY)

1.57
-0.07
( -4.27% )
Updated: 03:28:20

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.57
Bid
1.55
Ask
1.57
Volume
25,677
1.50 Day's Range 1.66
1.405 52 Week Range 3.45
Market Cap
Previous Close
1.64
Open
1.66
Last Trade
427
@
1.57
Last Trade Time
03:27:39
Financial Volume
-
VWAP
-
Average Volume (3m)
9,742
Shares Outstanding
26,022,590
Dividend Yield
-
PE Ratio
-4.15
Earnings Per Share (EPS)
-0.37
Revenue
3.89M
Net Profit
-9.59M

About Afyren

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Clermont-ferrand, Puy-de-dome, Fra
Founded
-
Afyren is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ALAFY. The last closing price for Afyren was 1.64 €. Over the last year, Afyren shares have traded in a share price range of 1.405 € to 3.45 €.

Afyren currently has 26,022,590 shares outstanding. The market capitalization of Afyren is 42.68 € million. Afyren has a price to earnings ratio (PE ratio) of -4.15.

ALAFY Latest News

AFYREN Announces Its Financial Calendar for Fiscal Year 2025

Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, announces...

AFYREN Provides Business Update and Announces a €10 Million Sustainable Financing for Its Subsidiary AFYREN NEOXY

AFYREN NEOXY business update : first acids sales in the second half of 2024 additional operational adjustments will be required to achieve continuous production in 2025 financial capacity...

AFYREN : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ

Regulatory News: Au titre du contrat de liquidité confié depuis le 2 novembre 2021 par la société AFYREN (Paris:ALAFY) à NATIXIS ODDO BHF, à la date du 31 décembre 2024, les moyens suivants...

AFYREN Obtains New Financing of 9 Million Euros to Support the Start-Up of AFYREN NEOXY

Regulatory News: AFYREN (Paris:ALAFY), a greentech company that offers manufacturers biobased, low-carbon ingredients produced using unique fermentation technology based on a completely circular...

AFYREN obtient la médaille d’argent ECOVADIS avec un score en progression

La médaille d'argent attribuée à AFYREN est confirmée par EcoVadis, leader en matière de notation de la durabilité, avec un score en progression de 7 points AFYREN se positionne parmi le top 15...

AFYREN annonce ses résultats financiers semestriels 2024

AFYREN NEOXY : premières commercialisations mais des ajustements opérationnels nécessaires pour atteindre la production en continu Objectif de production en continu d’ici fin 2024 maintenu, sous...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.21-11.7977528091.781.781.5172491.74356337DE
4-0.62-28.31050228312.192.451.5115691.97695185DE
12-0.82-34.3096234312.392.591.597422.13957814DE
26-1.21-43.52517985612.783.451.5132222.60989039DE
52-0.43-21.523.451.405241072.30754589DE
156-7.18-82.05714285718.758.91.405113722.92028273DE
260-6.06-79.42332896467.639.351.405111213.30312461DE

ALAFY - Frequently Asked Questions (FAQ)

What is the current Afyren share price?
The current share price of Afyren is 1.57 €
How many Afyren shares are in issue?
Afyren has 26,022,590 shares in issue
What is the market cap of Afyren?
The market capitalisation of Afyren is EUR 42.68M
What is the 1 year trading range for Afyren share price?
Afyren has traded in the range of 1.405 € to 3.45 € during the past year
What is the PE ratio of Afyren?
The price to earnings ratio of Afyren is -4.15
What is the cash to sales ratio of Afyren?
The cash to sales ratio of Afyren is 10.23
What is the reporting currency for Afyren?
Afyren reports financial results in EUR
What is the latest annual turnover for Afyren?
The latest annual turnover of Afyren is EUR 3.89M
What is the latest annual profit for Afyren?
The latest annual profit of Afyren is EUR -9.59M
What is the registered address of Afyren?
The registered address for Afyren is 9-11 RUE GUTENBERG, CLERMONT-FERRAND, PUY-DE-DOME, 63100
What is the Afyren website address?
The website address for Afyren is www.afyren.com
Which industry sector does Afyren operate in?
Afyren operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AELISAelis Farma SA
2.70 €
(17.39%)
1.39k
ALTAILighton
21.30 €
(9.29%)
25.21k
KERKering
269.30 €
(8.94%)
278.78k
ALMASMastrad
0.022 €
(8.91%)
3M
ALMUNMunic S.A.
0.70 €
(8.02%)
21.68k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
80
ALMDTMedian Technologies
3.485 €
(-25.69%)
206.16k
ALARFAdeunis
0.748 €
(-18.70%)
900
ALBOOBOOSTHEAT
0.0568 €
(-17.68%)
15.59k
ALDOLDolfines
3.43 €
(-13.82%)
11.66k
ATOAtos SE
0.0022 €
(4.76%)
61.92M
ALCYBCybergun
0.0001 €
(0.00%)
24.54M
BCPBanco Comercial Portugues SA
0.5164 €
(-0.42%)
17.12M
ALVERVergnet
0.0014 €
(0.00%)
9.47M
BIOSBiosenic
0.0049 €
(-2.00%)
3.44M

Discussion

View Full Feed
luckydude777 luckydude777 3 minutes ago
ACON liftoff
ACON
CashCowMoo CashCowMoo 5 minutes ago
Yeah, doesnt look like they were really doing much. Look like they had some land but not major helium production.
RHCCF
Fiberrevo9 Fiberrevo9 6 minutes ago
Considering yesterday's trading session, the different trades, the rising pps, i am convinced that good news will be released next week.
What reassures me too is that, during last week, we had three times a peak to about 0,098, down manipulated as always, to a lower end pps, but more buys an
KBLB
gdog gdog 6 minutes ago
done
NLST
tw0122 tw0122 12 minutes ago
.05 + 15% 3m traded
ACON
Seminole Red Seminole Red 14 minutes ago
Constitutional amendment to allow Trump third term introduced in the House

A Republican House member introduced a resolution to amend the U.S. Constitution to allow President Donald Trump — and any other future president — to be elected to serve a third term.
Rep. Andy Ogles of
Guido2 Guido2 15 minutes ago
Goa. I was born here.
FNMA
MagnetLover MagnetLover 17 minutes ago
No way. Or else he would be too busy Sam Altmanning himself.
FLCX
Peter J Peter J 20 minutes ago
It took .000774 to buy those 774 shares todays. Who does this?Very good Question, Badog. A VERY good question...

May I remind you that most of the times over the last years... it was exactly the other way around!

Now, who did/does this...? And why...?

ERHE
tw0122 tw0122 21 minutes ago
$7.51 still a little left for latecomers just cash it out now 
ALUR
10thMountain 10thMountain 25 minutes ago
Speaking of stair stepping…

https://stockcharts.com/c-sc/sc?s=FDCT&p=D&yr=1&mn=0&dy=0&i=t4669085127c&r=1737710215304
FDCT
RickNagra RickNagra 27 minutes ago
Which part of India are you in ?  I know the place very well.
FNMA
tw0122 tw0122 30 minutes ago
Flip back out .53 will revisit 
BTAI
Peter J Peter J 31 minutes ago
Ntephe and insiders are getting away with violating SEC filing and disclosure requirements, with refusing to hold annual shareholder meetings, and with paying themselves undisclosed amounts from undisclosed sources of revenue.

All very true, sounds like a stock I would like to follow
ERHE
RickNagra RickNagra 34 minutes ago
Oh wow.
DBMM
tw0122 tw0122 37 minutes ago
BTAI .49 on the move in some 
BTAI
Peter J Peter J 39 minutes ago
Couldn't use these shares as collateral to buy a rotisserie chicken at Costco.
Well... that firmly explains his obsession with ERHE... 🤣

The altruist gang has combined between 10 and 20 K ERHC posts...

Strategy, remember... all for the good cause! Don't
ERHE
joeycav11 joeycav11 45 minutes ago
Were so undervalued…
With this revenue a medium biotech company can buy us and multiply there balance sheet by 6 times easy.
Obviously company is not selling cheap
Shake up is coming in pharma dont miss it
Cell therapy is the panacea and proven cures like we possess is t
AMRN
Here Today Here Today 46 minutes ago
Another train of thought is that possibly those patients in the Cohorts 1 & 2 might have been talking to their family and friends about this new drug they are on and the results they are seeing so far causing those family and friends to start researching and looking into the company and drug and the
RNAZ
Ribo Ribo 46 minutes ago
$BDPT, Dominate the Mat with Xcellara!!!

https://x.com/BioadaptivesInc/status/1882612437301834189
BDPT
Ribo Ribo 47 minutes ago
$BDPT, The Science Behind Xcellera!!!

https://x.com/BioadaptivesInc/status/1882610070749581750
BDPT
eagle8 eagle8 48 minutes ago
Peter Davis
@peter_brit
·
2h
#dcvax $nwbo #gbm

GPT-4o (Poe) Analysis providing additional context to the Information Disclosure Statement added by $nwbo to their combination patent.

The patent applicant for 18/489,222 (related to "Combinatio
NWBO
Seminole Red Seminole Red 48 minutes ago
yay

Your Recent History

Delayed Upgrade Clock